Compensatory sweating is a phenomenon that refers to the appearance of excessive sweating in an untreated area, following the interruption of the sweating process elsewhere on the body. This term is especially known in the context of surgical interventions on the sympathetic nervous system, such as thoracic sympathectomy, where the risk of compensatory sweating is well documented.
In light of this surgical reality, some patients fear that treatment of hyperhidrosis with botulinum toxin, particularly in the underarms or hands, could cause a “relocation” of sweating to other regions of the body : back, thighs, legs, or even the face.
This concern is entirely legitimate, but it deserves a precise answer based on the available medical data.
Botulinum toxin acts locally on the cholinergic nerve endings that stimulate the sweat glands. By blocking the release of acetylcholine, it temporarily interrupts the nerve signal responsible for sweat secretion in the injected area.
Unlike a sympathectomy (which acts centrally and irreversibly), Botox does not alter the overall nerve architecture or the systemic regulation of sweating. It acts only on a well-defined zone, without interfering with the sweat glands located elsewhere in the body.
In other words, the body does not “redirect” its sweating. There is no proven neurological mechanism that would channel the blocked sweat to another area. This point is confirmed by the majority of scientific publications on the subject.
Clinical studies conducted over the past 20 years on the use of Botox for the treatment of hyperhidrosis, particularly axillary (underarm) hyperhidrosis, show an excellent safety profile. In the studied cohorts, compensatory sweating did not occur.
When patients report unusual sweating after treatment, it is most often an increased perception of areas that normally sweat (back, chest), or a confusion between normal sweating and a side effect.
In randomized controlled trials, no significant difference in overall sweating was observed between treated and untreated patients.
Dermatology and neurology experts therefore agree that Botox, when injected according to best practices, does not cause compensatory sweating.
In practice, patients very rarely report an increase in sweating in other areas. What can occur, however, is a new awareness of the body. When the problematic area stops sweating (often after years of discomfort), the patient becomes more attentive to other bodily sensations, which can create the illusion of sweating elsewhere.
One patient reports: “Since my underarms no longer sweat, I feel like I’m sweating more on my back. But in fact, that was already the case, I just wasn’t paying attention.”
This phenomenon of adjusting body perception is well known in functional medicine. It is not a real transfer, but a sensory re-evaluation, often temporary.
It is important to emphasize that, as with any medical treatment, an incorrect indication or a poorly adapted protocol can produce undesired effects. If a patient has generalized sweating and multiple areas are treated simultaneously, a temporary form of thermal imbalance may be observed.
However, these situations remain exceptional. In a professional setting, with a thorough clinical evaluation, the treatment is targeted, moderate, and does not present a significant risk of sweating dysregulation.
Botulinum toxin remains today the reference solution in the medical treatment of localized hyperhidrosis. Its safety, long-lasting effectiveness (4 to 6 months), and good tolerance make it a widely endorsed treatment, both by doctors and patients.
Unlike surgery, its effect is reversible. In the absence of renewal, sweating gradually returns to normal, without a sudden rebound or transfer to other areas.
The question of compensatory sweating is therefore, in this context, unnecessarily feared.
It is essential not to confuse the side effects associated with certain invasive surgical treatments with the effects observed with non-invasive medical treatments like botulinum toxin.
Thoracic sympathectomy, for example, is a surgical procedure intended to treat severe forms of hyperhidrosis, particularly palmar (hands). It involves cutting or destroying the sympathetic nerves located in the thorax, which are responsible for activating sweat glands in certain areas.
Although this technique can provide long-lasting relief, it often leads, in a significant percentage of cases (up to 80% according to some studies), to compensatory sweating.
Why does this happen ? Because sympathectomy acts centrally, irreversibly modifying a nerve loop. The body, unable to activate certain areas to dissipate heat, delegates the work to others. This rebalancing is unpredictable, sometimes disproportionate, and often very poorly tolerated.
In contrast, Botox has no central action. It does not interrupt the main nerve pathway but temporarily blocks local transmission of the sweat signal. Therefore, there is no modification of the overall thermal regulation circuit, nor a redistribution of sweating.
The human body has between 2 and 4 million sweat glands, distributed across the entire skin surface. These glands are controlled by a complex system, integrated into the autonomic nervous system, which regulates internal temperature according to physiological needs.
When body temperature rises (heat, physical effort, emotion), a signal is sent to the sweat glands to produce sweat, which, by evaporating, cools the body. This mechanism is finely tuned, distributed across the skin, and capable of functioning efficiently even if certain areas are temporarily at rest.
In this context, blocking sweating in a localized area — such as the underarms, palms, or forehead — with Botox injections represents only a partial inhibition of overall sweat capacity. In practice, this affects less than 3% of the total body surface.
The rest of the body continues to regulate temperature without strain or overload. It does not need to “compensate,” because thermal activity remains stable and controlled. Botox does not cause any disruption of thermal homeostasis. Patients do not experience an increase in body temperature or excessive sweating in other areas, even during intense exercise or extreme heat.
It is this physiological stability that explains the excellent tolerance of the treatment, even after multiple sessions, and in young or athletic patients.
The absence of compensatory sweating induced by botulinum toxin is now well established in the medical literature. Many professional societies have published precise recommendations on this subject, based on rigorous studies and long-term follow-up data.
The International Hyperhidrosis Society, the leading global organization dedicated to the management of hyperhidrosis, confirms in its protocols that “Type A botulinum toxin is a very safe treatment option for localized hyperhidrosis. No significant cases of compensatory sweating have been reported in clinical trials. Side effects are localized, transient, and infrequent.”
The European Academy of Dermatology and Venereology (EADV) includes Botox in the first-line treatment recommendations for axillary, palmar, and craniofacial hyperhidrosis, emphasizing its excellent safety profile.
Even regulatory agencies (such as the FDA in the United States) recognize that Botox treatment does not cause systemic disruption, and that its use can be repeated without loss of efficacy or the emergence of distant complications.
In summary, no reputable medical authority mentions compensatory sweating as a side effect of Botox. This point is now considered a major difference between medical and surgical approaches.
Article written by Dr Romano Valeria
SHARE THIS ARTICLE ON
